2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-105515
    TJN 220
    TJN 220 is a synthetic derivative of orally active tetrandrine (HY-13764). TJN 220 has a long-lasting and stable antihypertensive effect in various hypertension models. TJN 220 is suitable for controlling nighttime hypertension and does not cause reflex tachycardia. TJN 220 can be used for research on hypertension.
    TJN 220
  • HY-147539
    Antitumor agent-65
    Antitumor agent-65 (Compound 5) is an analogue/derivative of (-)-cleistenolide. Antitumor agent-65 has the potential for the research of cancer diseases.
    Antitumor agent-65
  • HY-100072
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate (Methyl (2E,4E,6Z)-decatrienoate) is the aggregation pheromone of the brown-winged green bug, Plautia stali. (2E,4E,6Z)-Methyl deca-2,4,6-trienoate exposed to daylight in solutions and/or on dispensers used for field trapping can readily isomerize to form complex mixtures of isomers, thus causing a concern about lure stability and longevity.
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate
  • HY-165497
    Felbinac tris
    Felbinac tris (4-Biphenylacetic acid tris) is a potent analgesic agent. Felbinac tris metabolized into 4'-hydroxyfelbinac and is excreted via urine and feces. Felbinac tris has the potential for the research of post-operative pain.
    Felbinac tris
  • HY-176896
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid)
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid) (Compound 8) is a key intermediate for the synthesis of porphyrin-chelate conjugate.
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid)
  • HY-N19859
    Everlastoside C
    Everlastoside C (Milliettiioside) (Compound 3) is a glycoside that can be found in the flowers of Helichrysum arenarium. Glycosidic compounds typically possess anti-inflammatory, anti-infective, anti-cancer, and antioxidant properties, playing a variety of important roles within biological organisms.
    Everlastoside C
  • HY-120695
    Nafiverine
    Nafiverine is an antispasmodic agent. Nafiverine shows a high myolytic activity on the smooth muscles of the ileum, uterus, and coronary vessels.
    Nafiverine
  • HY-178683
    ALV-05-077-01
    ALV-05-077-01 is a BLC6/BLC6B degrader. ALV-05-077-01 depletes endogenous BCL6 levels in SuDHL4 cells (high BCL6 expression) and BCL6B levels in KYO1 cells (high BCL6B expression). ALV-05-077-01 can be used for the study of hematological malignancies.
    ALV-05-077-01
  • HY-N1014
    11α,12β-Di-O-acetyltenacigenin B
    11α,12β-Di-O-acetyltenacigenin B is a polyoxypregnane compound isolated from the CHCl(3)-soluble fraction of the ethanolic extract of the stem of Marsdenia tenacissima.
    11α,12β-Di-O-acetyltenacigenin B
  • HY-149327
    Anticancer agent 131
    HCT-116-IN-1, a γ-lactam-fused pyridone derivative, has anticancer activity and displayed high cytotoxicity against HCT116 cells with an IC50 of 5.59 μM.
    Anticancer agent 131
  • HY-139723
    Antidepressant agent 2
    		Inhibitor
    Antidepressant agent 2 exerts pronounced antidepressant activity (MED 0.1 mg/kg).
    Antidepressant agent 2
  • HY-106486A
    Butoprozine hydrochloride
    Butoprozine hydrochloride functions as a cardiac depressant agent.
    Butoprozine hydrochloride
  • HY-121595
    5,5-Diphenylbarbituric acid
    5,5-Diphenylbarbituric acid is an organic compound belonging to the derivatives of barbituric acid. 5,5-Diphenylbarbituric acid can be used for seizure study.
    5,5-Diphenylbarbituric acid
  • HY-163009
    Dicamba-butyric acid
    Dicamba-butyric acid is an immunizing and heterologous hapten.
    Dicamba-butyric acid
  • HY-116131
    DAC-2-25
    DAC-2-25 is a molecule that causes a homeotic transformation of body column into tentacle zone.
    DAC-2-25
  • HY-149216
    Anticancer agent 103
    Anticancer agent 103 (Compound 2k) is a potent anticancer agent.
    Anticancer agent 103
  • HY-W176012
    Glycolate oxidase-IN-1
    Glycolate oxidase-IN-1(compound 26), a salicylic acid derivative, is a glycolate oxidase (GO) inhibitor with an IC50 of 38.2 μM. Glycolate oxidase-IN-1 has the ability to reduce oxalate production in hyperoxalate hepatocytes and can be used in the study of primary hyperoxaluria type 1 (PH1).
    Glycolate oxidase-IN-1
  • HY-103641AR
    (2S)-Octyl-α-hydroxyglutarate (Standard)
    CVT-2738 (Standard) is the analytical standard of CVT-2738. This product is intended for research and analytical applications. CVT-2738 is a Ranolazine (HY-B0280) Metabolite, and shows anti-myocardial ischemia activities.
    (2S)-Octyl-α-hydroxyglutarate (Standard)
  • HY-19680
    Prinomide tromethamine
    Prinomide tromethamine is an orally available nonsteroidal anti-inflammatory agent. Prinomide tromethamine can be used to study inflammation, such as rheumatoid arthritis.
    Prinomide tromethamine
  • HY-W550494
    1-(Pyridin-4-yl)heptan-1-one
    		Inhibitor
    1-(Pyridin-4-yl)heptan-1-one (Compound R=n-C₆H₁₃) is an anticonvulsant agent. 1-(Pyridin-4-yl)heptan-1-one can protect mice from electroshock-induced convulsions. 1-(Pyridin-4-yl)heptan-1-one is promising for research of convulsion-related diseases such as epilepsy.
    1-(Pyridin-4-yl)heptan-1-one
Cat. No. Product Name / Synonyms Application Reactivity